This paper aims to demonstrate how the speech measures which are collected to inform the therapy process also have the potential to evaluate clinical change and effectiveness. Certain methodological issues pertinent to evaluating therapy for early stuttering are raised and the clinical measures that are a part of the Lidcombe Programme (Onslow 1993) are discussed in relation to these. Reference to a single case study is made to demonstrate how the measures contribute to clinical decision-making. Some initial results of the authors' use of the Lidcombe Programme in the UK is outlined. |
